542918 — Gian Life Care Share Price
- IN₹165.05m
- IN₹226.87m
- IN₹131.20m
- 71
- 66
- 27
- 58
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 1.64 | ||
Price to Tang. Book | 1.64 | ||
Price to Free Cashflow | 33.24 | ||
Price to Sales | 1.38 | ||
EV to EBITDA | 4.07 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 22.72% | ||
Return on Equity | 29.83% | ||
Operating Margin | 41.95% |
Financial Summary
Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | IN₹m | 76.45 | 104.55 | 159.3 | 119.25 | 131.2 | n/a | n/a | 88.02% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +1365.38 | +37.1 | +116.86 | -75.65 | +290.29 | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Gian Life Care Limited is an India-based pathology provider. The Company is engaged in the business of providing diagnostic and related healthcare tests and services in various cities connecting Kanpur and nearby areas. The Company offers a range of approximately 1,344 tests, which includes various tests ranging from biochemistry, clinical pathology, coagulation, cytogenetics, cytology and hematology, among others. It is mainly engaged in the business of pathological investigations. The Company provides a range of diagnostic and related healthcare tests and services, such as patient diagnosis, prevention and wellness diagnosis services to its patients and healthcare providers. The Company is focused on opening several diagnostics labs in various parts of the state. Its subsidiaries include Gian Path Lab (India) Pvt Ltd and Gian Satguru Pathology LLP. Its customers include individual patients, hospitals, other healthcare providers and corporate customers.
Directors
- Avani Gupta CFO
- Vanshul Asnani CCO
- Arun Gupta MDR
- Rashika Agarwal NED
- Abhiram Agarwal NID
- Umang Gupta NID
- Last Annual
- March 31st, 2024
- Last Interim
- September 30th, 2024
- Incorporated
- November 6th, 2018
- Public Since
- January 13th, 2020
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
Bombay Stock Exchange
- Shares in Issue
- 10,341,524

- Address
- 7/216 (6) Swaroop Nagar, Kanpur, 208002
- Web
- https://gianlifecare.org/
- Phone
- Contact
- Rashika Agarwal
- Auditors
- M/s. MSNT & Associates LLP
Upcoming Events for 542918
Q1 2026 Gian Life Care Ltd Earnings Release
Gian Life Care Ltd Annual Shareholders Meeting
Similar to 542918
Aashka Hospitals
Bombay Stock Exchange
Abate As Industries
Bombay Stock Exchange
Asarfi Hospital
Bombay Stock Exchange
Aspira Pathlab & Diagnostics
Bombay Stock Exchange
Broach Lifecare Hospital
Bombay Stock Exchange
FAQ
As of Today at 20:49 UTC, shares in Gian Life Care are trading at IN₹16.39. This share price information is delayed by 15 minutes.
Shares in Gian Life Care last closed at IN₹16.39 and the price had moved by -19.97% over the past 365 days. In terms of relative price strength the Gian Life Care share price has underperformed the S&P BSE 100 Index by -24.61% over the past year.
There is no consensus recommendation for this security.
Find out moreGian Life Care does not currently pay a dividend.
Gian Life Care does not currently pay a dividend.
Gian Life Care does not currently pay a dividend.
To buy shares in Gian Life Care you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹16.39, shares in Gian Life Care had a market capitalisation of IN₹165.05m.
Here are the trading details for Gian Life Care:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 542918
Based on an overall assessment of its quality, value and momentum Gian Life Care is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Gian Life Care. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -12.42%.
As of the last closing price of IN₹16.39, shares in Gian Life Care were trading -16.29% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Gian Life Care PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹16.39.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Gian Life Care's management team is headed by:
- Avani Gupta - CFO
- Vanshul Asnani - CCO
- Arun Gupta - MDR
- Rashika Agarwal - NED
- Abhiram Agarwal - NID
- Umang Gupta - NID